Imagion Biosystems (ASX:IBX) up on deal to develop breast cancer treatment
Shares of Imagion Biosystems (ASX:IBX) jumped as much as 9% to AU$0.085, their highest since…
Imagion Biosystems Enters Agreement to Develop Nanocrystals for Treating Breast Cancer
Imagion Biosystems is pleased to announce it has entered into a Joint Development Agreement…
Phoenix and Maricopa County Proclaim July 21st as Glioblastoma Awareness Day
PHOENIX, July 21, 2021 /PRNewswire/ — In recognition of the local strides being made in the…
San Diego company aiming to target glioblastoma with nanotechnology-based approach
The emerging biopharmaceutical company Global Cancer Technology (GCT; San Diego) is…
BioSpace Movers & Shakers
Biopharma and life sciences organizations strengthen their leadership teams and board with…
What Will It Take to Bring Glioblastoma Research to the Forefront?
Dr. Loralyn Mears is the Director of Scientific Communications for Global Cancer Technology, and..
Global Cancer Technology to raise $9M through a Reg A+ offering to fund potential COVID treatment
Global Cancer Technology Inc CEO John Clark tells Proactive the privately-held biopharmaceutical…
Partnerships at Barrow Neurological Institute to Commercialize New Glioblastoma Treatment
Together with scientists from the University of California San Diego, Global Cancer Technology (GCT)…
Global Cancer Technology Signs Agreement with Barrow Neurological Institute to Commercialize
Global Cancer Technology Signs Agreement with Barrow Neurological Institute to…
A Novel Treatment Modality for COVID-19
Global Cancer Technology is Developing a Light-emitting Nanoparticle Which May…
Licenses Autophagy Modulators from Neuropore Therapies
GLOBAL CANCER TECHNOLOGY LICENSES AUTOPHAGY MODULATORS FROM NEUROPORE THERAPIES FOR
Global Cancer Technology Receives SEC Notice of Qualification for Reg A+ Tier II Registration
Company Plans to Raise $9 Million USD with Proceeds to Fund New COVID Treatment Using Nanoparticles, UV Light and…